Feb 19, 2013, 10.59 AM | Source: CNBC-TV18
Short Dr Reddys Laboratories, says Sudarshan Sukhani of s2analytics.com.
Sudarshan Sukhani (more)
Technical Analyst, s2analytics.com | Capital Expertise: Equity - Technical
Sukhani told CNBC-TV18, " Dr Reddys Laboratories is a sell and it is a surprise. It started falling and we thought that this is a correction, but it was not. It is now breaking all kinds of support levels and making a distribution pattern that promises that what we are looking at is an intermediate downtrend, not just a short-term correction.”
He further added, “I think perhaps it is company specific, but whatever the reason Dr Reddys is now a short selling idea. Even in a market that could go up probably this one is likely to underperform.”
The share touched its 52-week high Rs 1,968.60 and 52-week low Rs 1,555.00 on 25 January, 2013 and 19 June, 2012, respectively. Currently, it is trading 8.54% below its 52-week high and 15.79% above its 52-week low. Market capitalisation stands at Rs 30,579.91 crore.
Disclosure: I have no holdings or interest in the stock discussed.
Rajat Bose, Research Analyst at rajatkbose.com exp
In an interview with CNBC-TV18, Rajesh Kothari of
Sanjiv Bhasin of IIFL recommends buying Dr Reddy's
Dr Reddy's Laboratories has successfully completed